ID: ALA2172432

Max Phase: Preclinical

Molecular Formula: C14H12N2O2

Molecular Weight: 240.26

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC1=CC(c2ccco2)=N/C1=C\c1ccc[nH]1

Standard InChI:  InChI=1S/C14H12N2O2/c1-17-14-9-12(13-5-3-7-18-13)16-11(14)8-10-4-2-6-15-10/h2-9,15H,1H3/b11-8-

Standard InChI Key:  BFEXLZKQZVVJNY-FLIBITNWSA-N

Associated Targets(Human)

Protein-tyrosine phosphatase 1C 687 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 240.26Molecular Weight (Monoisotopic): 240.0899AlogP: 2.98#Rotatable Bonds: 3
Polar Surface Area: 50.52Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 2.49CX LogP: 1.47CX LogD: 1.47
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.90Np Likeness Score: -0.37

References

1. Su JC, Chen KF, Chen WL, Liu CY, Huang JW, Tai WT, Chen PJ, Kim I, Shiau CW..  (2012)  Synthesis and biological activity of obatoclax derivatives as novel and potent SHP-1 agonists.,  56  [PMID:22982119] [10.1016/j.ejmech.2012.08.024]

Source